Loading...
XJSE
DCP
Market cap1.51bUSD
May 06, Last price  
3,194.00ZAR
1D
-0.50%
1Q
-6.42%
Jan 2017
42.59%
IPO
52.82%
Name

Dis-Chem Pharmacies Ltd

Chart & Performance

D1W1MN
XJSE:DCP chart
No data to show
P/E
2,790.41
P/S
75.71
EPS
1.14
Div Yield, %
0.70%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
11.12%
Revenues
36.28b
+11.08%
10,320,999,00012,910,594,00015,061,293,00017,268,475,00019,560,462,00021,420,023,00023,984,296,00026,278,196,00030,406,611,00032,663,513,00036,283,476,000
Net income
984m
-1.57%
408,593,000433,654,000512,775,000612,346,000684,279,000734,723,000598,225,000668,687,000853,446,0001,000,224,000984,481,000
CFO
1.89b
+121.35%
51,903,000-234,976,000-668,312,000159,160,00045,023,000336,040,0001,256,978,0001,124,070,0001,377,575,000853,943,0001,890,205,000
Dividend
Jun 19, 202422.493 ZAR/sh
Earnings
May 29, 2025

Profile

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers a range of products, including dispensary, personal care and beauty, healthcare and nutrition, baby care products, and other products, as well as offers ancillary services that include healthcare clinics, and hair and beauty salons. The company also manages an online platform that provides click & collect services. In addition, it is involved in the wholesale of pharmaceutical, health, and front shop products; pharma-logistic services; and provision of customer loyalty programs. The company operates 289 stores across all nine provinces in South Africa, four in Namibia, and two in Botswana. The company was founded in 1978 and is headquartered in Midrand, South Africa.
URL
https://www.dischemgroup.com/
IPO date
Nov 18, 2016
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑022023‑022022‑022021‑022020‑022019‑022018‑022017‑022016‑02
Income
Revenues
36,283,476
11.08%
32,663,513
7.42%
Cost of revenue
29,020,825
25,866,126
Unusual Expense (Income)
NOPBT
7,262,651
6,797,387
NOPBT Margin
20.02%
20.81%
Operating Taxes
364,093
389,181
Tax Rate
5.01%
5.73%
NOPAT
6,898,558
6,408,206
Net income
984,481
-1.57%
1,000,224
17.20%
Dividends
(424,327)
(466,006)
Dividend yield
Proceeds from repurchase of equity
(65,485)
1,391,797
BB yield
Debt
Debt current
1,921,311
1,812,072
Long-term debt
6,836,760
6,389,706
Deferred revenue
501,479
Other long-term liabilities
(501,479)
Net debt
7,665,479
7,719,990
Cash flow
Cash from operating activities
1,890,205
853,943
CAPEX
(1,027,094)
(1,089,948)
Cash from investing activities
(1,062,361)
(1,090,644)
Cash from financing activities
(631,828)
(203,154)
FCF
6,153,381
7,290,577
Balance
Cash
884,371
287,385
Long term investments
208,221
194,403
Excess cash
Stockholders' equity
4,545,025
12,442,871
Invested Capital
10,164,887
8,686,607
ROIC
73.19%
78.16%
ROCE
70.93%
77.62%
EV
Common stock shares outstanding
858,116
860,362
Price
Market cap
EV
EBITDA
8,324,592
7,799,492
EV/EBITDA
Interest
586,007
370,446
Interest/NOPBT
8.07%
5.45%